Published in J Cardiovasc Pharmacol Ther on January 01, 2001
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet (2008) 5.85
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci U S A (1980) 2.88
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA (1990) 2.78
Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J Biol Chem (1997) 2.53
Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med (1994) 2.49
Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol (1983) 2.33
Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest (1973) 2.26
A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins. Anal Biochem (1973) 2.19
Apoprotein composition of very low density lipoproteins of human serum. J Clin Invest (1975) 2.18
Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest (1970) 2.17
A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res (1999) 2.13
Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier. Neuron (2001) 2.11
Neuromuscular and cardiovascular advantages of combinations of mivacurium and rocuronium over either drug alone. Anaesthesia (1996) 2.03
Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene. J Lipid Res (2001) 2.02
Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia. Arteriosclerosis (1983) 1.90
Isolation of a cDNA clone encoding the amino-terminal region of human apolipoprotein B. Proc Natl Acad Sci U S A (1986) 1.86
Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. J Lipid Res (1977) 1.80
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest (1981) 1.79
Chronic marginal iron intakes during early development in mice result in persistent changes in dopamine metabolism and myelin composition. J Nutr (2000) 1.74
Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc Natl Acad Sci U S A (1973) 1.66
Dietary preference for sweet foods in patients with dementia. J Am Geriatr Soc (1990) 1.57
Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol (1998) 1.55
Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency. J Clin Invest (1980) 1.54
Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol (1977) 1.53
Cholestasis: lamellar structure of the abnormal human serum lipoprotein. Science (1971) 1.51
Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein. J Clin Invest (1981) 1.50
Analysis of cDNA clones encoding the entire B-26 region of human apolipoprotein B. Proc Natl Acad Sci U S A (1986) 1.48
Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Arch Intern Med (1994) 1.46
Two genetically separable phases of growth inhibition induced by blue light in Arabidopsis seedlings. Plant Physiol (1998) 1.44
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb (1994) 1.42
Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J Infect Dis (1985) 1.39
Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci U S A (1984) 1.36
Metabolism of apoprotein B of plasma very low density lipoproteins in the rat. J Clin Invest (1975) 1.36
Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest (1993) 1.36
Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins. Proc Natl Acad Sci U S A (1982) 1.35
Factors affecting the integrity of high density lipoproteins in the ultracentrifuge. J Lipid Res (1982) 1.35
Effective patient care in the pediatric ambulatory setting: a study of the acute care clinic. Pediatrics (1969) 1.32
Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med (1984) 1.31
Apolipoprotein is responsible for neutralization of xenotropic type C virus by mouse serum. Proc Natl Acad Sci U S A (1979) 1.31
Fatty acid binding protein. Isolation from rat liver, characterization, and immunochemical quantification. J Biol Chem (1982) 1.26
Dispensing errors and counseling in community practice. Am Pharm (1995) 1.26
Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia. Circulation (1995) 1.26
Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma. J Clin Invest (1983) 1.25
Subunit heterogeneity in human serum beta lipoprotein. Proc Natl Acad Sci U S A (1970) 1.25
Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I. Proc Natl Acad Sci U S A (1984) 1.23
Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J Lipid Res (2000) 1.23
Chylomicrons can inhibit endotoxin activity in vitro. J Surg Res (1991) 1.18
Hypolipidemia. Med Clin North Am (1982) 1.17
Effects of hormones and pyruvate on the rates of secretion of very-low-density lipoprotein triacylglycerol and cholesterol by rat hepatocytes. Biochim Biophys Acta (1985) 1.17
Regulation of cholesterol synthesis in the liver and mammary gland of the lactating rat. Biochem J (1983) 1.17
Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest (1995) 1.17
Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci U S A (1983) 1.16
Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins. Proc Natl Acad Sci U S A (1977) 1.16
Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen. N Engl J Med (1981) 1.16
Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci U S A (1992) 1.14
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics (1991) 1.13
Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia. Nucleic Acids Res (1988) 1.13
Identification of proteins associated with apolipoprotein A-I-containing lipoproteins purified by selected-affinity immunosorption. Biochemistry (1994) 1.13
Relation of plasma lipid and apoprotein levels to progressive intimal hyperplasia after arterial endarterectomy. Circulation (1992) 1.12
Sequence-specific DNA recognition by the Myb-like domain of plant telomeric protein RTBP1. J Biol Chem (2000) 1.12
Clinical differences among women with and without self-reported perimenstrual asthma. Ann Allergy Asthma Immunol (1998) 1.11
Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med (1995) 1.09
Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study. Am Heart J (1987) 1.09
Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility. J Lipid Res (1985) 1.09
Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3. J Clin Invest (1983) 1.09
Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. Arteriosclerosis (1983) 1.08
Impact and cost of public health nurse telephone follow-up of school dental referrals. Am J Public Health (1986) 1.07
Changes in the sensitivity of lipogenesis in rat hepatocytes to hormones and precursors over the diurnal cycle and during longer-term starvation of donor animals. J Lipid Res (1984) 1.07
A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med (2001) 1.06
Drugs and lipid metabolism. Annu Rev Pharmacol (1973) 1.05
Degradable polyethylenimines as DNA and small interfering RNA carriers. Expert Opin Drug Deliv (2009) 1.04
Ichthyosis and neutral lipid storage disease. Am J Med Genet (1985) 1.02
Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation (1997) 1.02
A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med (1998) 1.01
Cryo-electron microscopy of low density lipoprotein and reconstituted discoidal high density lipoprotein: imaging of the apolipoprotein moiety. J Lipid Res (1997) 1.01
Determination of left ventricular volume in children: echocardiographic and angiographic comparisons. Circulation (1980) 1.01
Immunomodulation by 1,25-dihydroxyvitamin D3: therapeutic implications in hemodialysis and renal transplantation. Clin Nephrol (2006) 1.01
Utilization of endogenous and exogenous sources of substrate for cholesterol biosynthesis by isolated hepatocytes. Biochem J (1979) 1.01
The effect of ligand heterogeneity on the Scatchard plot. Particular relevance to lipoprotein binding analysis. J Biol Chem (1985) 1.00